Pharmaceutical Events in Netherlands

By industry
Date

CDMO Live

May 27, 2026 - May 28, 2026

A Central Platform for the CDMO and Biopharma Community

The concept behind CDMO Live is rooted in collaboration and technological progress. In an era where outsourcing plays an increasingly critical role in pharmaceutical production, this event provides a targeted, high-value platform for knowledge exchange, deal-making, and strategic alignment between developers, manufacturers, and service providers.

The annual gathering in Rotterdam provides an exceptional opportunity for participants to learn about emerging technologies, regulatory developments, and market dynamics in contract manufacturing. Whether it’s biologics, small molecules, or advanced therapies, the conference offers insights into every stage of the drug development and production lifecycle.

Key Objectives of CDMO Live

Facilitating Collaboration – connecting biopharma companies with trusted outsourcing partners.

Showcasing Innovation – presenting cutting-edge technologies and manufacturing solutions.

Sharing Expertise – offering a forum for thought leaders to discuss trends, challenges, and opportunities.

Driving Efficiency – helping organizations streamline development and production workflows.

Through this strategic focus, CDMO Live enables participants to navigate the rapidly evolving biopharmaceutical outsourcing landscape with clarity and confidence.

Rotterdam: A Strategic Hub for Biopharma Collaboration

The choice of Rotterdam as the host city reflects the event’s global and forward-looking perspective. As one of Europe’s most important logistical and industrial centers, Rotterdam provides a vibrant environment for international collaboration in science, trade, and technology.

The city’s modern infrastructure, excellent transport connections, and proximity to leading European biotech hubs make it an ideal venue for global professionals seeking to expand their networks. The event’s venue equipped with state-of-the-art conference and exhibition spaces—fosters meaningful discussions and high-level business interactions in a professional yet inspiring setting.

Why Rotterdam Is the Perfect Host City

Strategic European location with easy access to major biopharma clusters.

Strong life sciences ecosystem, home to research institutes and innovative companies.

World-class conference facilities supporting global events and exhibitions.

Commitment to sustainability and innovation, aligning with the future of pharma.

Rotterdam’s atmosphere of progress and connectivity perfectly complements CDMO Live’s mission to unite the global CDMO community under one roof.

A Specialized Forum for the Future of Biopharmaceutical Manufacturing

At the heart of CDMO Live lies a sharp focus on advancements in small molecules, biologics, and cell & gene therapy three pillars of modern biopharmaceutical innovation. The conference and exhibition highlight technologies and outsourcing strategies that help companies adapt to increasing regulatory complexity, rising production costs, and accelerating product timelines.

The event goes beyond conventional trade fairs by offering in-depth discussions, technical presentations, and strategic networking opportunities. This approach ensures that attendees gain actionable insights and build partnerships that extend far beyond the duration of the event.

Core Themes and Discussion Topics

Innovations in Biologics and Biosimilars – advancing production and quality assurance.

Cell and Gene Therapy Manufacturing – overcoming technical and scalability challenges.

Process Optimization and Digitalization – integrating AI, automation, and data analytics.

Regulatory Compliance and Global Supply Chains – addressing market access and safety.

Outsourcing Strategy and Risk Management – balancing flexibility with long-term partnerships.

By focusing on these themes, CDMO Live encourages participants to embrace innovation, mitigate challenges, and redefine efficiency in pharmaceutical manufacturing.

PharmaSource and Life Science Networks: The Visionaries Behind the Event

The driving force behind CDMO Live is the partnership between PharmaSource and Life Science Networks, two organizations committed to supporting growth and excellence within the life sciences industry.

PharmaSource is a well-established platform providing professionals with market insights, industry news, podcasts, and training programs focused on procurement and outsourcing. It acts as a resource hub for understanding best practices and staying up to date with global market movements.

Behind PharmaSource stands Life Science Networks, a leading organizer of specialized events and industry collaborations. Together, they have shaped CDMO Live into a trusted meeting ground where knowledge, innovation, and opportunity intersect.

Their Shared Mission

Empowering professionals through access to relevant and timely information.

Building networks that connect companies across the value chain.

Driving innovation by organizing events that inspire collaboration.

Enhancing industry standards through education and communication.

This partnership ensures that CDMO Live is not just another event it is a strategic experience designed to strengthen the global CDMO community.

PartnerMatch: Facilitating One-on-One Business Connections

A highlight of CDMO Live is the PartnerMatch 1-on-1 meeting program, which provides an efficient and personalized way for companies to identify and connect with potential partners. This initiative allows participants to schedule face-to-face business meetings, maximizing their time and creating tangible collaboration opportunities.

Alongside PartnerMatch, the event hosts roundtable discussions, market analyses, and panel sessions that explore real-world challenges and success stories. These sessions foster open dialogue between executives, scientists, and consultants ensuring a 360-degree view of the industry’s most pressing topics.

Networking and Engagement Opportunities

PartnerMatch 1-on-1 Meetings – targeted networking for partnership development.

Roundtable Discussions – in-depth exploration of industry trends.

Workshops and Case Studies – sharing practical approaches to outsourcing challenges.

Market Insight Panels – featuring leaders from top CDMO and biotech organizations.

This interactive environment turns CDMO Live into a collaborative knowledge hub, where strategy meets innovation and business development takes on new dimensions.

Where the Future of Outsourcing Takes Shape

The CDMO Live conference and exhibition has rapidly positioned itself as a must-attend event for professionals in the pharmaceutical and biotechnology sectors. By bringing together thought leaders, manufacturers, and service providers, it has become a cornerstone of the global outsourcing and manufacturing landscape.

Hosted annually in Rotterdam and organized by PharmaSource and Life Science Networks, CDMO Live provides not just a showcase of innovation but also a forum for action where ideas turn into partnerships and strategies evolve into tangible results.

For organizations aiming to stay at the forefront of biopharmaceutical manufacturing, CDMO Live is more than an event it’s a strategic opportunity to explore the latest trends, build lasting collaborations, and prepare for the next chapter of the life sciences industry.

World Drug Safety Congress Europe

September 23, 2026 - September 24, 2026

World Drug Safety Congress Europe – Advancing Pharmacovigilance and Patient Safety

The World Drug Safety Congress Europe, held annually at the RAI Amsterdam, is one of the most influential events dedicated to drug safety, pharmacovigilance, and risk management in the pharmaceutical and biotechnology sectors. Organized by Terrapinn Holdings Ltd., the congress has established itself as a central hub for professionals across pharmacy, biotech, and medical technology to explore the latest developments, innovations, and best practices in ensuring patient safety. With its comprehensive program, the event attracts regulatory experts, industry leaders, academic researchers, and technology innovators from around the globe.

Amsterdam, renowned for its status as a center for medical research and development, provides the perfect backdrop for the congress. The RAI Amsterdam offers modern facilities, excellent accessibility, and a professional environment that supports large-scale exhibitions, interactive workshops, and high-level networking opportunities, making it an ideal venue for this international gathering.

Exploring cutting-edge innovations in drug safety

At the heart of the World Drug Safety Congress Europe is a focus on practical and innovative solutions for pharmacovigilance. Attendees gain exposure to emerging tools and strategies that enhance patient safety and optimize operational efficiency, including:

Artificial intelligence and automation for risk assessment and signal detection

Natural language processing systems for analyzing safety reports and literature

Advanced monitoring platforms for real-time pharmacovigilance

Cost-effective AI applications that streamline regulatory compliance

Data analytics tools for evaluating safety trends and generating actionable insights

By showcasing these solutions, the congress helps professionals implement smarter, faster, and more reliable safety protocols in their organizations, ensuring that pharmacovigilance keeps pace with the rapidly evolving healthcare landscape.

Comprehensive education and expert-led sessions

A distinguishing feature of the congress is its combination of high-level education and hands-on practical learning. The program includes:

Interactive workshops and case studies demonstrating real-world applications of drug safety strategies

Panel discussions addressing regulatory challenges, quality control, and patient-centric approaches

Seminars on advanced analytical techniques and emerging technologies in pharmacovigilance

Debates on the ethical and operational implications of AI and digital health tools in safety monitoring

These sessions provide participants with actionable knowledge, enabling them to enhance their organizations’ safety frameworks and stay at the forefront of regulatory and technological advancements.

Networking and interdisciplinary collaboration

The congress brings together a diverse range of stakeholders, including pharmaceutical companies, biotechnology firms, regulatory agencies, academic institutions, and technology providers. This diversity encourages cross-industry collaboration, knowledge exchange, and the formation of strategic partnerships. Whether during networking sessions, informal meetups, or workshops, attendees have ample opportunity to connect with leading experts and decision-makers, fostering a community dedicated to improving drug safety worldwide.

Global significance and strategic impact

As part of a global series of drug safety congresses, the European edition underscores the international importance of pharmacovigilance. By addressing challenges such as compliance, signal detection, and patient-centered monitoring, the event provides a platform for sharing knowledge and implementing solutions that have a worldwide impact. The congress covers the full spectrum of drug safety, from digital health tools and safety databases to advanced analytics and automation, making it indispensable for professionals seeking the latest insights and strategies.

Driving progress in pharmacovigilance

Ultimately, the World Drug Safety Congress Europe combines knowledge, innovation, and practical application to deliver a comprehensive experience for all attendees. Participants leave with:

Exposure to cutting-edge technologies that improve efficiency and compliance

Insights into global regulatory standards and emerging industry trends

Opportunities to collaborate with experts from diverse sectors

Practical tools and strategies to enhance patient safety

In conclusion, the congress is an essential event for pharmaceutical, biotechnology, and healthcare professionals who are committed to advancing drug safety and improving outcomes for patients worldwide. By uniting innovation, education, and international networking, it remains a cornerstone for anyone involved in pharmacovigilance and regulatory science.

Dutch Hematology Congress

January 22, 2025 - January 24, 2025
Completed

The Dutch Hematology Congress (DHC) is a premier event in the field of hematology, bringing together experts, clinicians, researchers, and healthcare professionals to discuss the latest advancements, treatments, and policies in hematology care. The upcoming edition of the DHC promises to be an exciting and informative gathering, covering a range of critical topics, including the CGR Code of Conduct, congress policies, the DHC program, and a special Nursing Symposium.

One of the key aspects of the event will be a comprehensive focus on the CGR Code of Conduct, a vital framework for ethical practices in healthcare, particularly in relation to the pharmaceutical and medical device industries. This session will offer invaluable insights for all participants on maintaining high standards of professional conduct, ensuring transparency, and fostering ethical collaboration in the field of hematology.

In addition to this, the congress will provide a detailed overview of the DHC program, offering attendees a chance to learn about the latest developments in hematology, from groundbreaking research to innovative treatment options. As always, the congress will feature renowned speakers and experts who will share their insights on the most pressing issues in the field.

For the first time, this year's congress will also include a dedicated Nursing Symposium, focusing on the role of nurses in hematology care. This symposium will provide a platform for nursing professionals to engage with the latest research, improve their skills, and discuss best practices for supporting patients with blood disorders.

Preparations for edition of the DHC are already underway, with organizers working closely with speakers and moderators to ensure a smooth and impactful event. As the congress approaches, participants will receive essential information to help them prepare for the event, ensuring that the DHC continues to be a vital and enriching experience for all involved.

The Dutch Hematology Congress remains a cornerstone event for hematology professionals, offering a unique opportunity to exchange knowledge, discuss the latest scientific developments, and collaborate with experts in the field. It is an essential event for anyone interested in advancing their understanding of hematology and improving patient care in this critical area of medicine.